| 2000 |
Human SVCT1 (SLC23A1) mediates saturable, concentrative, high-affinity L-ascorbic acid transport (K0.5 = 50–100 µM) that is electrogenic, sodium-dependent, and inhibited by phloretin. The transporter displays exquisite substrate selectivity, greatly favoring L-ascorbic acid over D-isoascorbic acid, dehydroascorbic acid, and 2- or 6-substituted analogues, while excluding glucose and nucleobases. |
Radiotracer uptake and voltage-clamp assays in cRNA-injected Xenopus oocytes |
Biochemical and biophysical research communications |
High |
10631088
|
| 2002 |
Slc23a1 knockout mice have less than 5% of normal ascorbic acid uptake in cultured embryonic fibroblasts, undetectable or markedly reduced ascorbic acid in blood and tissues, and die within minutes of birth with respiratory failure and intraparenchymal brain hemorrhage. Prenatal supplementation failed to elevate fetal blood ascorbic acid, demonstrating that Slc23a1 is required for placental ascorbic acid transport. |
Knockout mouse model; ascorbic acid uptake assays in cultured fibroblasts; tissue ascorbic acid measurement; histopathology |
Nature medicine |
High |
11984597
|
| 2002 |
SVCT1 expression is up-regulated ~4-fold at the mRNA level during post-confluent differentiation of CaCo-2 cells and is selectively sorted to the apical membrane compartment in polarized epithelial monolayers, where it is the sole functional ascorbic acid transporter mediating vectorial uptake across the intestinal barrier. |
Real-time quantitative PCR; transport kinetics; apical vs. basolateral functional assays in Transwell filter inserts; RT-PCR |
The Journal of biological chemistry |
High |
12381735
|
| 2002 |
High-dose ascorbic acid (4.5 mg/ml for 24 h) significantly reduces SVCT1 mRNA expression (~77%) and L-ascorbic acid uptake (~50%) in Caco-2 TC7 intestinal epithelial cells, indicating that SVCT1 is subject to substrate-dependent transcriptional down-regulation. |
RT-PCR for SVCT1 mRNA; radiolabeled 14C-ascorbic acid uptake assay |
The British journal of nutrition |
Medium |
11895172
|
| 2005 |
SVCT1-EGFP localizes predominantly to the apical membrane of confluent Caco-2 and MDCK epithelial cells, and expression of SVCT1 increases transport activity from the apical membrane, establishing a non-redundant apical function distinct from the basolateral function of SVCT2. |
EGFP-tagged SVCT expression constructs; confocal microscopy; Transwell ascorbate transport assays in MDCK and Caco-2 cells; SVCT2-knockout enterocytes |
Biochemical and biophysical research communications |
High |
15993839
|
| 2006 |
UVB irradiation increases vitamin C uptake into keratinocytes in a time- and dose-dependent manner through translocation of SVCT1 from the cytosol to the plasma membrane, thereby enabling vitamin C to suppress UVB-induced IL-8 and MCP-1 production. |
Vitamin C uptake assays; subcellular fractionation/translocation imaging; RNase protection assay; ELISA for chemokine protein levels |
The Journal of investigative dermatology |
Medium |
17008880
|
| 2007 |
SVCT1 mediates L-ascorbic acid transport with a Na+:ascorbate coupling ratio of 2:1, with an ordered simultaneous binding mechanism (Na+, L-ascorbic acid, Na+). Pre-steady-state currents in the absence of ascorbate, described by single Boltzmann distributions, indicate that the first Na+ binds partway within the membrane electric field (ion-well effect). A detailed transport model was established. |
Simultaneous radiotracer flux and voltage-clamp measurements in Xenopus oocytes; pre-steady-state current analysis; model simulation |
American journal of physiology. Cell physiology |
High |
18094143
|
| 2009 |
The differential apical (SVCT1) vs. basolateral (SVCT2) membrane targeting in epithelial cells is determined hierarchically: an N-terminal basolateral targeting sequence (BTS) present in SVCT2 but not SVCT1 drives basolateral localization; its destruction redirects SVCT2 apically. A C-terminal sequence in both SVCTs is required for plasma membrane incorporation/retention; its deletion causes intracellular accumulation of both transporters. Default targeting for SVCT is apical. |
Domain swaps, deletions, insertions, and point mutations on EGFP-tagged hSVCT1/hSVCT2; stable expression in MDCK cells; confocal microscopy; Transwell ascorbate transport assays |
Biochemistry |
High |
19216494
|
| 2010 |
Ascorbic acid depletion in SMP30/GNL knockout mice (unable to synthesize ascorbic acid) enhances SVCT1 mRNA expression in the liver and small intestine, and increases actual ascorbic acid uptake in primary cultured hepatocytes, indicating that intracellular ascorbic acid negatively regulates SVCT1 expression. |
SMP30/GNL knockout mice; RT-PCR for SVCT1/SVCT2 mRNA; radiotracer ascorbic acid uptake in primary hepatocytes |
Archives of biochemistry and biophysics |
Medium |
20122894
|
| 2010 |
Transcriptional regulation of hSVCT1 in human liver epithelial cells (HepG2) requires HNF-1 binding sites in the hSVCT1 promoter for basal activity and for adaptive (ascorbic acid-responsive) regulation; ascorbic acid deprivation increases and supplementation decreases hSVCT1 mRNA, protein, and promoter activity via HNF-1 sites, whereas hSVCT2 promoter/expression is unaffected. |
Promoter-reporter constructs; mutational analysis of cis-elements; 14C-ascorbic acid uptake; RT-PCR and protein expression in HepG2 cells under ascorbic acid-deficient/supplemented conditions |
The Journal of nutritional biochemistry |
Medium |
20471816
|
| 2012 |
Rab8a co-localizes with hSVCT1 in intestinal cells and is required for proper apical membrane targeting of hSVCT1; knockdown of Rab8a reduces cell-surface expression of hSVCT1 (leading to lysosomal mis-trafficking revealed by LAMP1 co-localization) and significantly inhibits ascorbic acid uptake. Rab8a knockout mice show similarly reduced intestinal ascorbic acid uptake and decreased mSVCT1 protein. |
Co-localization by confocal microscopy; siRNA knockdown; cell-surface biotinylation; 14C-ascorbic acid uptake; Rab8a knockout mouse intestinal uptake assays; LAMP1 co-localization |
Digestive diseases and sciences |
High |
23014846
|
| 2013 |
SLC23A1 does not mediate ascorbic acid efflux/release in the proximal renal epithelial cell; using a dual-transporter Xenopus oocyte system and mammalian cells overexpressing SLC23A1, no ascorbate release was detected, establishing that SLC23A1 functions exclusively in ascorbate uptake across the apical membrane of proximal tubule cells. |
Dual-transporter Xenopus oocyte efflux assay; mammalian cell overexpression; gene expression profiling of human proximal tubule segments |
Physiological reports |
Medium |
24400138
|
| 2013 |
Purified human SVCT1 (hSVCT1) exists predominantly as a monomer with a minor dimeric population in detergent solution; chemical crosslinking of isolated oocyte membranes also shows predominantly monomeric and minor dimeric states in lipid bilayers. The protein is glycosylated when expressed in Xenopus oocytes. |
Expression in Xenopus oocytes; protein purification; transmission electron microscopy and single-particle analysis; chemical crosslinking |
PloS one |
Medium |
24124560
|
| 2023 |
Cryo-EM structures of mouse SVCT1 in apo and substrate-bound states show that SVCT1 forms a homodimer, with each protomer containing a core domain and a gate domain. Vitamin C binds at the core domain of each subunit with two sodium ions coordinated near the binding site. The tightly packed extracellular interfaces stabilize an inward-open conformation. Transport likely proceeds via an elevator mechanism combined with local structural rearrangements. |
Cryo-electron microscopy of apo and substrate-bound mouse SVCT1; structural analysis of sodium ion coordination and substrate binding site |
Nature communications |
High |
36914666
|
| 2023 |
SVCT1 functions as a sodium-dependent low-affinity/high-capacity urate transporter in addition to its ascorbic acid transport role, as demonstrated by mammalian cell-based transport assays for human SVCT1 and mouse Svct1. Svct1 knockout mice in a hyperuricemic background have lower serum urate than controls, suggesting a physiological role for Svct1 in renal urate reuptake. |
Mammalian cell-based transport assays (human SVCT1 and mouse Svct1); CRISPR-Cas9 Svct1 knockout mice crossed into hyperuricemic (uricase-deficient) background; serum urate measurement |
Pflugers Archiv : European journal of physiology |
Medium |
36749388
|
| 2015 |
Species-specific transcriptional regulation of SVCT1 in rat vs. human hepatoma cells involves distinct cis-regulatory elements: Bach1 and HNF4 binding sites are critical for rat SVCT1 promoter activity but absent at equivalent positions in the human promoter, while HNF1 sites critical for human SVCT1 regulation are present in the rat promoter but do not affect its activity. |
Promoter cloning; deletion and mutant reporter constructs; site-directed mutagenesis; transfection into rat H4IIE and human HepG2 hepatoma cells with transcription factor co-expression |
Free radical biology & medicine |
Medium |
25933589
|
| 2011 |
Iron exposure up-regulates SVCT1 protein expression (~24%) in ascorbic acid-deficient Caco-2 cells and correlates with a ~285% increase in ascorbic acid uptake, demonstrating that iron regulates SVCT1 expression and ascorbic acid transport in intestinal epithelial cells. |
ELISA and Western blot for SVCT1 protein; radiolabeled ascorbic acid uptake; SVCT1 inhibitor (quercetin) validation in Caco-2 cells on Transwell inserts |
The British journal of nutrition |
Medium |
21418708
|